High Alert
STAT

STAT+: FDA approves new pancreatic cancer drug expected to usher in new era of treatment

STAT+: FDA approves new pancreatic cancer drug expected to usher in new era of treatmentWorldPing

The FDA has approved a life-extending treatment for advanced pancreatic cancer — the first such therapy to attack a genetic cause of the highly lethal malignancy.

This is a short WorldPing brief. The full report was published by STAT.

Read the full report at STAT

Related news

Flight attendant’s breast cancer was occupational disease, court rulesWorldPing
The Guardian

Flight attendant’s breast cancer was occupational disease, court rules

Sophie Lainault, who worked for Air France, wins legal case linking illness to more than 12,600 hours on flights A flight attendant in France has succeeded in having her breast cancer recognised as an occupational disease, a first for the country’s a…

Brief by WorldPing · Original reporting by The Guardian